05/21/2025
3:33 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
8:30 AM | Avoro Capital Advisors LLC (Filed by)
Blueprint Medicines (Subject)
| Form SCHEDULE 13G | |
05/12/2025
9:44 AM | Blueprint Medicines (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/05/2025
3:57 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
6:12 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2025
3:16 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/24/2025
3:20 PM | Blueprint Medicines (Filer)
| Form DEFA14A | |
04/23/2025
7:19 PM | BlackRock, Inc. (Filed by)
Blueprint Medicines (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:30 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
3:27 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:04 PM | Blueprint Medicines (Subject)
Rossi Christina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for BPMC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Blueprint Medicines and its competitors with MarketBeat's FREE daily newsletter. |
03/17/2025
3:26 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:36 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:12 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:13 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:14 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:15 PM | Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:16 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:17 PM | Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:18 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:18 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:19 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:20 PM | Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:20 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:21 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
4:15 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2025
4:09 PM | Blueprint Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
6:34 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
6:53 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:54 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
6:56 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:23 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
8:25 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
3:24 PM | Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
5:03 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
5:04 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:50 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
10:55 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:15 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:15 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
4:17 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
I was wrong. Dead wrong. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
12/18/2024
3:31 PM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
6:51 PM | Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
3:52 PM | Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
4:33 PM | Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:52 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
12:40 PM | Blueprint Medicines (Subject)
Haviland Kate (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
5:51 PM | Blueprint Medicines (Subject)
Rossi Christina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:47 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
3:23 PM | Blueprint Medicines (Subject)
COATS LONNEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
12:44 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144/A | |
11/07/2024
4:24 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:27 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:07 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:09 PM | Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:06 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:22 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2024
3:27 PM | Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
4:06 PM | Blueprint Medicines (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
3:50 PM | Blueprint Medicines (Subject)
Lee Philina (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:48 PM | Blueprint Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
6:29 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
6:07 PM | Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:08 PM | Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Blueprint Medicines (Subject)
Durso-Bumpus Debra (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
3:36 PM | Blueprint Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:32 PM | Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:34 PM | Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:35 PM | Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:36 PM | Blueprint Medicines (Issuer)
Tsai John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:37 PM | Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:38 PM | Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:41 PM | Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:11 PM | Blueprint Medicines (Subject)
Carter Percy H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
3:40 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Blueprint Medicines (Subject)
Hewes L. Becker (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
7:00 AM | Blueprint Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy BPMC Stock Free BPMC Stock Alerts